Skip to main content
SD BIOSENSOR INC. logo

SD BIOSENSOR INC. — Investor Relations & Filings

Ticker · 137310 ISIN · KR7137310009 KO Manufacturing
Open in API
Filings indexed 337 across all filing types
Latest filing 2025-08-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 137310

About SD BIOSENSOR INC.

https://www.sdbiosensor.com/

SD BIOSENSOR INC. is an in-vitro diagnostics company that develops, manufactures, and supplies point-of-care (POC) diagnostic solutions. The company specializes in rapid diagnostic tests (RDTs), biosensors, and diagnostic reagents aimed at the early and accurate diagnosis, prevention, and management of diseases. A key product is the STANDARD M, a point-of-care molecular diagnostics (MDx) system designed for fast and simple clinical decision-making near the patient. Through its focus on innovative biosensor technology, the company aims to improve the quality of life by providing accessible and reliable diagnostic tools.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for SD Biosensor, covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial data, business operations, management discussions, and corporate governance information. As it is a comprehensive financial report for a period shorter than a full fiscal year (half-year) and includes substantive financial statements and analysis, it falls under the 'Interim / Quarterly Report' category. H1 2025
2025-08-13 Korean
기업지배구조보고서공시
Governance Information Classification · 1% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) for SD Biosensor, Inc. It details the company's governance structure, board composition, shareholder rights, and compliance with governance indicators. This type of report is a standard regulatory filing in South Korea, specifically mandated for listed companies to disclose their corporate governance practices. It does not fit into categories like 10-K (Annual Report), ER (Earnings Release), or CT (Call Transcript). It is a formal governance disclosure document, which falls under the 'Governance Information' category.
2025-05-30 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 1% confidence The document is a short announcement (708 characters) regarding the scheduling of an Investor Relations (IR) meeting to discuss Q1 2025 financial results. It explicitly states that the actual IR presentation materials will be published on the company website at a later time. Following the 'Menu vs Meal' rule, this is an announcement of a report/presentation rather than the presentation itself, making it a Report Publication Announcement (RPA).
2025-05-29 Korean
기타경영사항(자율공시)
Regulatory Filings Classification · 1% confidence The document is a short, voluntary disclosure (자율공시) regarding the receipt of a corporate tax refund due to a tax correction request. It does not fit into specific categories like financial reports, proxy statements, or share transactions. As it is a regulatory announcement of a specific corporate event that does not fall into the other defined categories, it is classified as a general regulatory filing.
2025-05-26 Korean
유형자산처분결정
Regulatory Filings Classification · 1% confidence The document is a formal regulatory announcement regarding the disposal of tangible assets (real estate) by SD Biosensor. It details the asset, the transaction amount, the counterparty, the purpose (liquidity and investment), and the board approval date. Since this is a specific corporate event disclosure that does not fit into the other specialized categories like M&A, share issues, or financial reports, it falls under the general regulatory filing category.
2025-05-20 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for SD Biosensor, covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial and operational information, including business overview, product sales, production capacity, and risk management. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.